Combined biomarkers evaluation for diagnosing kidney injury in preeclampsia

Hypertension in Pregnancy

Volumn 32, Issue 4, 2013, Pages 439-449

  Xiao, Jing ^a   Niu, Jianying ^a   Ye, Xianwu ^a   Yu, Qianqian ^a   Gu, Yong ^a,b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Biomarkers; Gestational hypertension; Kidney injury; Kidney injury molecule 1; Preeclampsia

Indexed keywords

BIOLOGICAL MARKER; CREATININE; CYSTATIN C; INTERLEUKIN 18; KIDNEY INJURY MOLECULE 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; RETINOL BINDING PROTEIN;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; KIDNEY INJURY; MATERNAL HYPERTENSION; PREECLAMPSIA; PREGNANCY; SENSITIVITY AND SPECIFICITY; SYSTOLIC BLOOD PRESSURE; URINE LEVEL;

ACUTE-PHASE PROTEINS; ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; CYSTATIN C; FEMALE; HUMANS; INTERLEUKIN-18; LIPOCALINS; MEMBRANE GLYCOPROTEINS; PRE-ECLAMPSIA; PREGNANCY; PROTO-ONCOGENE PROTEINS; RECEPTORS, VIRUS; RENAL INSUFFICIENCY; RETINOL-BINDING PROTEINS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84884804625     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.3109/10641955.2013.827203     Document Type: Article

References (28)

1. Krane NK, Hamrahian M. Pregnancy: Kidney diseases and hypertension. Am J Kidney Dis 2007;49:336-45
2. Shah A, Fawole B, M'Imunya JM, et al. Cesarean delivery outcomes from the WHO global survey on maternal and perinatal health in Africa. Int J Gynaecol Obstet 2009;107:191-7
3. McClure EM, Saleem S, Pasha O, Goldenberg RL. Stillbirth in developing countries: A review of causes, risk factors and prevention strategies. J Matern Fetal Neonatal Med 2009;22:183-90
4. Lapaire O, Grill S, Lalevee S, et al. Microarray screening for novel preeclampsia biomarker candidates. Fetal Diagn Ther 2012;31:147-53
5. Chen G, Zhang Y, Jin X, et al. Urinary proteomics analysis for renal injury in hypertensive disorders of pregnancy with iTRAQ labeling and LC-MS/MS. Proteomics Clin Appl 2011;5:300-10
6. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S1-22
7. Saetun P, Semangoen T, Thongboonkerd V. Characterizations of urinary sediments precipitated after freezing and their effects on urinary protein and chemical analyses. Am J Physiol Renal Physiol 2009;296:F1346-54
8. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate. Ann Int Med 2006;145:247-54
9. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Int Med 2009;150:604-12
10. Wagner LK. Diagnosis and management of preeclampsia. Am Fam Physician 2004; 70:2317-24
11. Jeyabalan A, Conrad KP. Renal function during normal pregnancy and preeclampsia. Front Biosci 2007;12:2425-37
12. Gonzalez F, Vincent F. Biomarkers for acute kidney injury in critically ill patients. Minerva Anestesiol 2012;78:1394-403
13. Pavkov ME, Knowler WC, Hanson RL, et al. Comparison of serum cystatin C, serum creatinine, measured GFR, and estimated GFR to assess the risk of kidney failure in American Indians with diabetic nephropathy. Am J Kidney Dis 2013;62: 33-41
14. Shlipak MG, Mattes MD, Peralta CA. Update on cystatin C: Incorporation into clinical practice. Am J Kidney Dis 2013. [Epub ahead of print]. doi: 10.1053/ j.ajkd.2013.03.027
15. Shlipak MG, Praught ML, Sarnak MJ. Update on cystatin C: New insights into the importance of mild kidney dysfunction. Curr Opin Nephrol Hypertens 2006;15: 270-5
16. Adiyanti SS, Loho T. Acute kidney injury (AKI) biomarker. Acta Med Indones 2012; 44:246-55
17. Chew JS, Saleem M, Florkowski CM, George PM. Cystatin C-A paradigm of evidence based laboratory medicine. Clin Biochem Rev 2008;29:47-62
18. Pereira AB, Nishida SK, Vieira JG, et al. Monoclonal antibody-based immunoenzymometric assays of retinol-binding protein. Clin Chem 1993;39:472-6
19. Chinen R, Camara NO, Nishida S, et al. Determination of renal function in longterm heart transplant patients by measurement of urinary retinol-binding protein levels. Braz J Med Biol Res 2006;39:1305-13
20. Bolignano D, Coppolino G, Romeo A, et al. Neutrophil gelatinase- Associated lipocalin (NGAL) reflects iron status in haemodialysis patients. Nephrol Dial Transplant 2009;24:3398-403
21. Cai L, Rubin J, Han W, et al. The origin of multiple molecular forms in urine of HNL/NGAL. Clin J Am Soc Nephrol 2010;5:2229-35
22. Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-Associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005; 365:1231-8
23. Nickolas TL, O'Rourke MJ, Yang J, et al. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-Associated lipocalin for diagnosing acute kidney injury. Ann Int Med 2008;148:810-19
24. Woo KS, Choi JL, Kim BR, et al. Urinary neutrophil gelatinase-Associated lipocalin levels in comparison with glomerular filtration rate for evaluation of renal function in patients with diabetic chronic kidney disease. J Diabetes Metab 2012;36:307-13
25. Zhang Z, Humphreys BD, Bonventre JV. Shedding of the urinary biomarker kidney injury molecule-1 (KIM-1) is regulated by MAP kinases and juxtamembrane region. J Am Soc Nephrol 2007;18:2704-14
26. Waanders F, Vaidya VS, van Goor H, et al. Effect of renin-Angiotensin- Aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: A post hoc analysis of a randomized controlled trial. Am J Kidney Dis 2009;53:16-25
27. Parikh CR, Jani A, Melnikov VY, et al. Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis 2004;43:405-14
28. Nickolas TL, Barasch J, Devarajan P. Biomarkers in acute and chronic kidney disease. Curr Opin Nephrol Hypertens 2008;17:127-32